• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶菌噬菌体控制多重耐药性禽致病性(APEC)感染。

A lytic phage to control multidrug-resistant avian pathogenic (APEC) infection.

机构信息

Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China.

Tianjin Key Laboratory of Agricultural Animal Breeding and Healthy Husbandry, College of Animal Science and Veterinary Medicine, Tianjin Agricultural University, Tianjin, China.

出版信息

Front Cell Infect Microbiol. 2023 Sep 7;13:1253815. doi: 10.3389/fcimb.2023.1253815. eCollection 2023.

DOI:10.3389/fcimb.2023.1253815
PMID:37743864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10513416/
Abstract

The inappropriate use of antibiotics has led to the emergence of multidrug-resistant strains. Bacteriophages (phages) have gained renewed attention as promising alternatives or supplements to antibiotics. In this study, a lytic avian pathogenic (APEC) phage designated as PEC9 was isolated and purified from chicken farm feces samples. The morphology, genomic information, optimal multiplicity of infection (MOI), one-step growth curve, thermal stability, pH stability, antibacterial ability and biofilm formation inhibition ability of the phage were determined. Subsequently, the therapeutic effects of the phages were investigated in the mice model. The results showed that PEC9 was a member of the siphovirus-like by electron microscopy observation. Biological characterization revealed that it could lyse two serotypes of , including O1 (9/20) and O2 (6/20). The optimal multiplicity of infection (MOI) of phage PEC9 was 0.1. Phage PEC9 had a latent period of 20 min and a burst period of 40 min, with an average burst size of 68 plaque-forming units (PFUs)/cell. It maintained good lytic activity at pH 3-11 and 4-50°C and could efficiently inhibit the bacterial planktonic cell growth and biofilm formation, and reduce bacterial counts within the biofilm, when the MOI was 0.01, 0.1, and 1, respectively. Whole-genome sequencing showed that PEC9 was a dsDNA virus with a genome of 44379 bp and GC content of 54.39%. The genome contains 56 putative ORFs and no toxin, virulence, or resistance-related genes were detected. Phylogenetic tree analysis showed that PEC9 is closely related to phages vB_EcoS_Zar3M, vB_EcoS_PTXU06, SECphi18, ZCEC10, and ZCEC11, but most of these phages exhibit different gene arrangement. The phage PEC9 could successfully protect mice against APEC infection, including improved survival rate, reduced bacterial loads, and organ lesions. To conclude, our results suggest that phage PEC9 may be a promising candidate that can be used as an alternative to antibiotics in the control of APEC infection.

摘要

抗生素的不当使用导致了多药耐药菌株的出现。噬菌体(phages)作为抗生素的替代品或补充品,重新引起了人们的关注。在这项研究中,从鸡场粪便样本中分离和纯化了一种溶菌性禽致病性(APEC)噬菌体,命名为 PEC9。测定了噬菌体的形态、基因组信息、最佳感染复数(MOI)、一步生长曲线、热稳定性、pH 稳定性、抗菌能力和生物膜形成抑制能力。随后,在小鼠模型中研究了噬菌体的治疗效果。结果表明,PEC9 通过电子显微镜观察属于类似丝状噬菌体的成员。生物学特性表明,它可以裂解两种血清型,包括 O1(9/20)和 O2(6/20)。噬菌体 PEC9 的最佳感染复数(MOI)为 0.1。噬菌体 PEC9 的潜伏期为 20 分钟,爆发期为 40 分钟,平均爆发大小为 68 个噬菌斑形成单位(PFU)/细胞。当 MOI 分别为 0.01、0.1 和 1 时,噬菌体 PEC9 在 pH 3-11 和 4-50°C 下保持良好的溶菌活性,能有效抑制浮游细胞生长和生物膜形成,并降低生物膜内的细菌计数。全基因组测序表明,PEC9 是一种双链 DNA 病毒,基因组大小为 44379 bp,GC 含量为 54.39%。基因组包含 56 个推定的 ORFs,未检测到毒素、毒力或耐药相关基因。系统发育树分析表明,PEC9 与噬菌体 vB_EcoS_Zar3M、vB_EcoS_PTXU06、SECphi18、ZCEC10 和 ZCEC11 密切相关,但这些噬菌体的基因排列大多不同。噬菌体 PEC9 能成功保护小鼠免受 APEC 感染,包括提高存活率、降低细菌负荷和器官损伤。综上所述,我们的研究结果表明,噬菌体 PEC9 可能是一种有前途的候选药物,可作为控制 APEC 感染的抗生素替代品。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/733b/10513416/8a9d04cff275/fcimb-13-1253815-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/733b/10513416/aec44df058d9/fcimb-13-1253815-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/733b/10513416/13961390b903/fcimb-13-1253815-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/733b/10513416/e1bdac78e2e3/fcimb-13-1253815-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/733b/10513416/4bbf713f2ac4/fcimb-13-1253815-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/733b/10513416/4e66c18eace3/fcimb-13-1253815-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/733b/10513416/965f9c3f014c/fcimb-13-1253815-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/733b/10513416/8a9d04cff275/fcimb-13-1253815-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/733b/10513416/aec44df058d9/fcimb-13-1253815-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/733b/10513416/13961390b903/fcimb-13-1253815-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/733b/10513416/e1bdac78e2e3/fcimb-13-1253815-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/733b/10513416/4bbf713f2ac4/fcimb-13-1253815-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/733b/10513416/4e66c18eace3/fcimb-13-1253815-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/733b/10513416/965f9c3f014c/fcimb-13-1253815-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/733b/10513416/8a9d04cff275/fcimb-13-1253815-g007.jpg

相似文献

1
A lytic phage to control multidrug-resistant avian pathogenic (APEC) infection.溶菌噬菌体控制多重耐药性禽致病性(APEC)感染。
Front Cell Infect Microbiol. 2023 Sep 7;13:1253815. doi: 10.3389/fcimb.2023.1253815. eCollection 2023.
2
Therapeutics and prophylactic efficacy of novel lytic Escherichia phage vB_EcoS_PJ16 against multidrug-resistant avian pathogenic E. coli using in vivo study.新型裂解埃希氏噬菌体 vB_EcoS_PJ16 对多药耐药禽致病性大肠杆菌的治疗和预防效果的体内研究。
Int Microbiol. 2024 Jun;27(3):673-687. doi: 10.1007/s10123-023-00420-7. Epub 2023 Aug 26.
3
The Isolation and Characterization of Bacteriophages Infecting Avian Pathogenic O1, O2 and O78 Strains.《感染禽致病性 O1、O2 和 O78 株的噬菌体的分离和特性描述》。
Viruses. 2023 Oct 16;15(10):2095. doi: 10.3390/v15102095.
4
Isolation, Characterization and Whole Genome Analysis of an Avian Pathogenic Phage vB_EcoS_GN06.禽致病性噬菌体vB_EcoS_GN06的分离、鉴定及全基因组分析
Vet Sci. 2022 Dec 5;9(12):675. doi: 10.3390/vetsci9120675.
5
[Biological characteristics and genomic information of a bacteriophage against pan-drug resistant in a burn patient and its effects on bacterial biofilm].[烧伤患者中一株抗泛耐药菌噬菌体的生物学特性、基因组信息及其对细菌生物膜的影响]
Zhonghua Shao Shang Za Zhi. 2020 Jan 20;36(1):14-23. doi: 10.3760/cma.j.issn.1009-2587.2020.01.004.
6
Identification and characterization of two bacteriophages with lytic activity against multidrug-resistant Escherichia coli.鉴定和表征两种具有裂解活性的噬菌体,可对抗多重耐药性大肠杆菌。
Virus Res. 2021 Jan 2;291:198196. doi: 10.1016/j.virusres.2020.198196. Epub 2020 Oct 21.
7
Isolation and Characterization of a Novel Phage Collection against Avian-Pathogenic .分离鉴定抗禽致病性 的新型噬菌体集
Microbiol Spectr. 2023 Jun 15;11(3):e0429622. doi: 10.1128/spectrum.04296-22. Epub 2023 May 4.
8
Characterization and genome analysis of a broad lytic spectrum bacteriophage P479 against multidrug-resistant Escherichia coli.一株针对多重耐药性大肠杆菌的广谱裂解性噬菌体P479的特性鉴定与基因组分析
Virus Res. 2022 Jan 15;308:198628. doi: 10.1016/j.virusres.2021.198628. Epub 2021 Nov 13.
9
Bacteriophage activity against and characterisation of avian pathogenic Escherichia coli isolated from colibacillosis cases in Uganda.抗禽致病性大肠杆菌噬菌体活性及其特征分析,这些大肠杆菌分离自乌干达大肠杆菌病病例。
PLoS One. 2020 Dec 15;15(12):e0239107. doi: 10.1371/journal.pone.0239107. eCollection 2020.
10
In vitro evaluation of two novel Escherichia bacteriophages against multiple drug resistant avian pathogenic Escherichia coli.体外评估两种新型大肠杆菌噬菌体对多重耐药禽致病性大肠杆菌的作用。
BMC Infect Dis. 2024 May 16;24(1):497. doi: 10.1186/s12879-024-09402-0.

引用本文的文献

1
[Application of phages in farm animals, food and the environment as part of a One Health approach-potentials and challenges].[噬菌体在农场动物、食品及环境中的应用——作为“同一健康”方法的一部分:潜力与挑战]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2025 May 20. doi: 10.1007/s00103-025-04055-z.
2
Evolutionary responses of Escherichia coli to phage pressure: insights into mucoidy and colanic acid overexpression.大肠杆菌对噬菌体压力的进化反应:对黏液化和柯氏酸过表达的见解。
BMC Genomics. 2025 May 6;26(1):448. doi: 10.1186/s12864-025-11605-x.
3
Molecular characterization of avian pathogenic Escherichia coli strains in Jiangxi Province, China, and development of polyvalent inactivated vaccines.

本文引用的文献

1
Phage family classification under : A review of current tools using the latest ICTV classification framework.噬菌体家族分类如下:使用最新国际病毒分类委员会(ICTV)分类框架的当前工具综述。
Front Microbiol. 2022 Dec 16;13:1032186. doi: 10.3389/fmicb.2022.1032186. eCollection 2022.
2
Isolation, Molecular Characterization, and Antibiotic Resistance of Avian Pathogenic in Eastern China.中国东部地区禽致病性大肠杆菌的分离、分子特征及抗生素耐药性
Vet Sci. 2022 Jun 25;9(7):319. doi: 10.3390/vetsci9070319.
3
Characterization, genome analysis and in vitro activity of a novel phage vB_EcoA_RDN8.1 active against multi-drug resistant and extensively drug-resistant biofilm-forming uropathogenic Escherichia coli isolates, India.
中国江西省禽致病性大肠杆菌菌株的分子特征及多价灭活疫苗的研制
Poult Sci. 2025 Feb;104(2):104766. doi: 10.1016/j.psj.2025.104766. Epub 2025 Jan 1.
4
Genome sequencing of phage reveals a novel lytic species.噬菌体的基因组测序揭示了一种新型裂解性物种。
3 Biotech. 2025 Jan;15(1):10. doi: 10.1007/s13205-024-04172-7. Epub 2024 Dec 15.
5
Phage therapeutic delivery methods and clinical trials for combating clinically relevant pathogens.用于对抗临床相关病原体的噬菌体治疗递送方法及临床试验。
Ther Deliv. 2025 Mar;16(3):247-269. doi: 10.1080/20415990.2024.2426824. Epub 2024 Nov 15.
6
Avian Pathogenic : An Overview of Infection Biology, Antimicrobial Resistance and Vaccination.禽致病性:感染生物学、抗菌药物耐药性及疫苗接种概述
Antibiotics (Basel). 2024 Aug 26;13(9):809. doi: 10.3390/antibiotics13090809.
7
Isolation and identification of specific phage C-3 and G21-7 against Avian pathogenic and its application to one-day-old geese.抗禽致病性的特异性噬菌体C-3和G21-7的分离鉴定及其在1日龄雏鹅中的应用
Front Microbiol. 2024 Jun 19;15:1385860. doi: 10.3389/fmicb.2024.1385860. eCollection 2024.
一种新型噬菌体vB_EcoA_RDN8.1的特性、基因组分析及其对印度多药耐药和广泛耐药的形成生物膜的尿路致病性大肠杆菌分离株的体外活性
J Appl Microbiol. 2022 Apr;132(4):3387-3404. doi: 10.1111/jam.15439. Epub 2022 Jan 17.
4
A century of phage therapy: from novel discoveries about the past to the challenges of the today.噬菌体疗法百年史:从过去的新发现到今天的挑战。
Pharmazie. 2021 Oct 1;76(10):519-521. doi: 10.1691/ph.2021.1114.
5
Characterization and Application of a Lytic Phage D10 against Multidrug-Resistant .溶菌噬菌体 D10 的特性分析及其在多重耐药
Viruses. 2021 Aug 17;13(8):1626. doi: 10.3390/v13081626.
6
Characterization of a Broad-Host-Range Lytic Phage SHWT1 Against Multidrug-Resistant and Evaluation of Its Therapeutic Efficacy and .一种针对多重耐药菌的广宿主范围裂解性噬菌体SHWT1的特性鉴定及其治疗效果评估 以及 。 (注:原文最后“and.”表述不完整,可能存在信息缺失。)
Front Vet Sci. 2021 Jun 10;8:683853. doi: 10.3389/fvets.2021.683853. eCollection 2021.
7
Avian Pathogenic (APEC): An Overview of Virulence and Pathogenesis Factors, Zoonotic Potential, and Control Strategies.禽致病性大肠杆菌(APEC):毒力与致病因素、人畜共患病潜力及控制策略概述
Pathogens. 2021 Apr 12;10(4):467. doi: 10.3390/pathogens10040467.
8
Bacteriophage activity against and characterisation of avian pathogenic Escherichia coli isolated from colibacillosis cases in Uganda.抗禽致病性大肠杆菌噬菌体活性及其特征分析,这些大肠杆菌分离自乌干达大肠杆菌病病例。
PLoS One. 2020 Dec 15;15(12):e0239107. doi: 10.1371/journal.pone.0239107. eCollection 2020.
9
Isolation and application of bacteriophages alone or in combination with nisin against planktonic and biofilm cells of Staphylococcus aureus.单独或联合使用噬菌体和乳链菌肽对抗金黄色葡萄球菌浮游细胞和生物膜细胞的分离和应用。
Appl Microbiol Biotechnol. 2020 Jun;104(11):5145-5158. doi: 10.1007/s00253-020-10581-4. Epub 2020 Apr 4.
10
Biological challenges of phage therapy and proposed solutions: a literature review.噬菌体治疗的生物学挑战及解决方案:文献综述
Expert Rev Anti Infect Ther. 2019 Dec;17(12):1011-1041. doi: 10.1080/14787210.2019.1694905. Epub 2019 Dec 2.